Skip to main content
Michael Kolodziej, MD, Oncology, Albany, NY

MichaelKolodziejMD

Oncology Albany, NY

Physician

Dr. Kolodziej is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Kolodziej's full profile

Already have an account?

  • Office

    400 Patroon Creek Blvd
    Suite 1
    Albany, NY 12206
    Phone+1 518-489-0044
    Fax+1 518-489-3591

Education & Training

  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 1987 - 1991
  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1984 - 1987
  • Washington University in St. Louis School of Medicine
    Washington University in St. Louis School of MedicineClass of 1984

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1997 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012

Publications & Presentations

PubMed

Lectures

  • Virginia Association of Hematologists and Oncologists - VAHO Spring Membership Conference 
    Virginia Association of Hematologists and Oncologists (VAHO), Hot Springs, Virginia - 4/26/2013

Press Mentions

  • Maximizing the Potential of Precision Medicine
    Maximizing the Potential of Precision MedicineOctober 7th, 2024
  • Canopy Launches Platform-Wide Support for Bispecific Antibodies
    Canopy Launches Platform-Wide Support for Bispecific AntibodiesSeptember 25th, 2024
  • “Damning It with Faint Praise?” the Future of Anti-TIGIT Therapy in NSCLC
    “Damning It with Faint Praise?” the Future of Anti-TIGIT Therapy in NSCLCApril 24th, 2023
  • Join now to see all